Literature DB >> 16177390

Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines.

Erin E McClelland1, Wesley T Perrine, Wayne K Potts, Arturo Casadevall.   

Abstract

Serial passage of Cryptococcus neoformans in mice increases virulence relative to the nonpassaged line. Postpassaged lines showed no difference in the expression of most known virulence factors, with the exception that the more virulent lines had smaller capsules in vitro. These data imply that other mechanisms of virulence remain to be discovered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177390      PMCID: PMC1230917          DOI: 10.1128/IAI.73.10.7047-7050.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Urease as a virulence factor in experimental cryptococcosis.

Authors:  G M Cox; J Mukherjee; G T Cole; A Casadevall; J R Perfect
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Lipid peroxidation by alveolar macrophages challenged with Cryptococcus neoformans, Candida albicans or Aspergillus fumigatus.

Authors:  N T Gross; K Hultenby; S Mengarelli; P Camner; C Jarstrand
Journal:  Med Mycol       Date:  2000-12       Impact factor: 4.076

3.  Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages.

Authors:  L Liu; R P Tewari; P R Williamson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans.

Authors:  K J Kwon-Chung; B L Wickes; J L Booth; H S Vishniac; J E Bennett
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

5.  Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans.

Authors:  G M Cox; H C McDade; S C Chen; S C Tucker; M Gottfredsson; L C Wright; T C Sorrell; S D Leidich; A Casadevall; M A Ghannoum; J R Perfect
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

6.  Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.

Authors:  S P Franzot; J Mukherjee; R Cherniak; L C Chen; J S Hamdan; A Casadevall
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  Monoclonal antibody based ELISAs for cryptococcal polysaccharide.

Authors:  A Casadevall; J Mukherjee; M D Scharff
Journal:  J Immunol Methods       Date:  1992-09-18       Impact factor: 2.303

8.  Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; S Mousseau; P Auger
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine.

Authors:  L Pirofski; R Lui; M DeShaw; A B Kressel; Z Zhong
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.

Authors:  S D Salas; J E Bennett; K J Kwon-Chung; J R Perfect; P R Williamson
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  12 in total

1.  Estimating the relative contributions of virulence factors for pathogenic microbes.

Authors:  Erin E McClelland; Paul Bernhardt; Arturo Casadevall
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

2.  New insights on the pathogenesis of invasive Cryptococcus neoformans infection.

Authors:  Helene C Eisenman; Arturo Casadevall; Erin E McClelland
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

3.  Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.

Authors:  Tiffany Guess; Hoyin Lai; Serenah E Smith; Linda Sircy; Kirsten Cunningham; David E Nelson; Erin E McClelland
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

4.  Most environmental isolates of Cryptococcus neoformans var. grubii (serotype A) are not lethal for mice.

Authors:  Anastasia P Litvintseva; Thomas G Mitchell
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

5.  Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo.

Authors:  Allan Jefferson Guimarães; Susana Frases; Radamés J B Cordero; Leonardo Nimrichter; Arturo Casadevall; Joshua D Nosanchuk
Journal:  Cell Microbiol       Date:  2010-01-11       Impact factor: 3.715

6.  Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage.

Authors:  Reginaldo dos Santos Pedroso; Joseane Cristina Ferreira; Marco Aurélio Sicchiroli Lavrador; Claudia Maria Leite Maffei; Regina Celia Candido
Journal:  Mycopathologia       Date:  2009-04-11       Impact factor: 2.574

7.  A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.

Authors:  Edmond J Byrnes; Wenjun Li; Ping Ren; Yonathan Lewit; Kerstin Voelz; James A Fraser; Fred S Dietrich; Robin C May; Sudha Chaturvedi; Sudha Chatuverdi; Vishnu Chaturvedi; Vishnu Chatuverdi; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

8.  Cryptococcus gattii VGIII isolates causing infections in HIV/AIDS patients in Southern California: identification of the local environmental source as arboreal.

Authors:  Deborah J Springer; R Blake Billmyre; Elan E Filler; Kerstin Voelz; Rhiannon Pursall; Piotr A Mieczkowski; Robert A Larsen; Fred S Dietrich; Robin C May; Scott G Filler; Joseph Heitman
Journal:  PLoS Pathog       Date:  2014-08-21       Impact factor: 6.823

9.  Role of CTR4 in the Virulence of Cryptococcus neoformans.

Authors:  Scott R Waterman; Yoon-Dong Park; Meera Raja; Jin Qiu; Dima A Hammoud; Thomas V O'Halloran; Peter R Williamson
Journal:  MBio       Date:  2012-10-02       Impact factor: 7.867

10.  Microevolution during serial mouse passage demonstrates FRE3 as a virulence adaptation gene in Cryptococcus neoformans.

Authors:  Guowu Hu; Shu Hui Chen; Jin Qiu; John E Bennett; Timothy G Myers; Peter R Williamson
Journal:  mBio       Date:  2014-04-01       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.